Antibodies for Characterizing SARS-CoV-2-Induced Immune Responses

Antibodies for Characterizing SARS-CoV-2-Induced Immune Responses

For some individuals, infection with SARS-CoV-2 can result in the development of moderate to severe acute respiratory distress syndrome (ARDS). One of the main features of ARDS is the cytokine storm, which is an uncontrolled systemic inflammatory response resulting from the excessive production of proinflammatory cytokines and chemokines. Clinical investigations of patients severely ill with COVID-19 have shown that these individuals display cytokine storm symptoms. Despite these findings, the immune response to SARS-CoV-2 infection is still only partially understood.

We offer an extensive selection of antibodies validated for flow cytometry that allow you to detect and analyze specific cell surface and intracellular markers in order to identify and characterize different immune cell types and cell type-specific subsets activated in response to SARS-CoV-2 infection. Browse R&D Systems and Novus Biologicals™ selection of flow cytometry antibodies. Or explore our Interactive Cell Marker Tool to find cell surface and intracellular markers used to identify different immune cell types. Markers link directly to R&D Systems and Novus Biologicals products, making it easy to find antibodies. Additionally, Bio-Techne offers workflow solutions for investigating the role of different immune cells, such as monocytesmacrophagesdendritic cellsnatural killer cellsT cells and B cells, in the immunopathogenesis of COVID-19.

Visit Bio-Techne's Immunology Workflow Solutions site to view products for:

  • Immune Cell Selection and Culture
  • Immune Cell Identification and Characterization
  • Modulation of Immune Cells
  • Investigation and Quantification of Immune Responses

Additionally, visit our main Antibodies for Coronavirus Research page for more information on our antibodies and related resources for SARS-CoV-2 research.